Paradoxically, high NLRC5 expression appeared to favor cancer progression in hepatocellular carcinoma, by stimulating tumor proliferation via the AKT pathway and promoting epithelial-to-mesenchymal transition (EMT) via Wnt/β-catenin signaling [91,92]. The gene discussed is NLRC5; the disease is cancer.